Sign in
NGEN Stock Price, Chart, Stats & News
NervGen Pharma Corp. Common stock
Save
NervGen Pharma Corp. Common stock (NGEN) does not currently pay a dividend.
161.10M
Market cap
–
Current P/E
–
Forward P/E
NGEN chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -195.93% |
ROE | 239118.67% |
D/E | -0.01x |
Interest coverage ratio | – |
NGEN valuation
P/E | – |
P/S | – |
P/B | -126.78x |
P/CF | -22.47x |
P/FCF | -24.33x |
P/OCF | -22.47x |
PEG | -3.93x |
EV multiple | -16.24x |
About
NervGen Pharma Corp. is a biotechnology enterprise currently in its clinical development phase, focused on devising therapeutic solutions for nerve injuries and progressive neurodegenerative diseases.
Similar securities
Based on sector and market capitalization
Report issue